Morning Hubsters, John R Fischer here with the US Wire from the New York newsroom. In times of uncertainty and slow dealmaking like now, investors look to fragmented markets to keep activity flowing. The insurance market is one of them. PE Hub’s Iris Dorbian rounded up eight deals in 2025 that sum up why firms like Ares, GTCR and Lightyear Capital are flocking toward the sector. Another space that investors are looking to consolidate is the urology market. In this week’s Friday Focus, we take a look at a merger agreement between a Gauge Capital portfolio company and a business recently sold by Apollo. Fragmentation is also among the reasons private equity is drawn towards the autism therapy segment. This morning, we delve into Bourne Partner’s Autism Therapy Market Update that points out another unique trend that may help increase PE involvement in the space. Ripe for consolidation Even with the current dealmaking slump, PE dollars continue to flow into the insurance sector. PE Hub ‘s Iris Dorbian tracked eight notable deals in this segment that have transpired since the beginning of this year. Upgrade to the premium version of the Wire to read the full list of deals in the insurance space. Friday Focus Earlier this week, Gauge Capital announced an agreement to merge its portfolio company Urology America, a management service organization of independent urology practices, with GI Alliance, a physician-led gastroenterology practice based in Southlake, Texas. To learn more about this deal and the trends driving dealmakers toward the urology sector, check out the premium Wire. Reimbursement drivers Pressures on fee-per-service reimbursement is driving autism therapy providers to explore transitioning to value-based reimbursement, which may drive many of these companies to become PE-backed, according to Bourne Partners’ Autism Therapy Market Update report. The autism sector has many tailwinds that make it highly attractive to PE, many of which I covered in my autism mini-feature – the most read story at PE Hub in April with over 3,500 page views – where I spoke with Calex, Goldman Sachs Alternatives and Shore Capital Partners. Check out the premium version of the Wire to read more of my insights from the report. Well, that’s it for me. As always, if you have any questions, thoughts or want to chat, please email me at [email protected]. A scheduling note before I sign off: with Monday being a bank holiday in the UK, the next Europe edition of the Wire will hit inboxes Tuesday. The US edition will go ahead as normal on Monday. Rafael Canton fills in for MK Flynn in the US chair, while Craig McGlashan will bring you the Europe edition on Tuesday. Cheers, John Read the full wire commentary on PE Hub ... |